PR

Prenetics Global Limited

PREConsumer DefensiveNASDAQ

Packaged Foods · Last scanned Sep 8, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$92.4M
+479.8% YoY
Net Income
-$37.7M
+18.6% YoY
EBITDA
-$32.2M
+19.4% YoY
Free Cash Flow
-$36.1M

Scan Results

Daily timeframe
4 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Sep 3 RSI OverboughtRSI 76.8, above 70, stock may be overbought
Sep 2 RSI OverboughtRSI 78.3, above 70, stock may be overbought
About Prenetics Global Limited

Prenetics Global Limited operates as a consumer health sciences company in the United States and Hong Kong. With a market capitalization of $426.9M, it sits in small-cap territory. The company focuses on advancing human health and longevity through science-backed products under the IM8 brand.

Where PRE stands vs its 150-day and 200-day moving averages

As of the September 3, 2026 close, PRE finished 35.75% above its 150-day moving average ($19.19) and 42.51% above its 200-day moving average ($18.28). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is PRE overbought or oversold?

At the September 3, 2026 close, PRE's RSI(14) was 76.8, in overbought territory (above 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$426.9M
Fwd P/E-9.51
EPS$-3.46
Beta0.31
52W Change+173.6%
ROE-47.0%
Analysis

Prenetics Global Limited holds $128.6M in cash against $682K in total debt, giving it a net cash position. This means the company could theoretically pay off all its debt and still have cash remaining. Free cash flow is running at -$36.1M, which bears watching. Negative free cash flow can be acceptable during heavy investment periods but needs to improve over time. Return on equity stands at -47.0%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Revenue has grown from $13.2M (2022) to $92.4M (2025), reflecting a 602% increase over the period.

With a beta below 0.7, Prenetics Global Limited typically sees smaller price swings than the overall market, offering a degree of stability during turbulent periods. With cash comfortably exceeding debt, PRE has financial flexibility that may help navigate uncertain periods. Negative free cash flow means the company is currently spending more than it generates, which may require future fundraising or debt if the trend continues. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Prenetics Global Limited and its sector.

Links
More Consumer Defensive stocks
Browse all stocks →
Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms